Literature DB >> 24578058

Bone marrow uptake of (99m)Tc-MIBI in patients with multiple myeloma.

D Blocklet1, E Schoutens, A Kentos, W Feremans.   

Abstract

Entities:  

Year:  2001        PMID： 24578058     DOI： 10.1007/s002590100576

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN： 0340-6997


× No keyword cloud information.
  2 in total

1.  Uptake of the cation hexakis(2-methoxyisobutylisonitrile)-technetium-99m by human carcinoma cell lines in vitro.

Authors:  L I Delmon-Moingeon; D Piwnica-Worms; A D Van den Abbeele; B L Holman; A Davison; A G Jones
Journal:  Cancer Res       Date:  1990-04-01       Impact factor: 12.701

2.  Technetium-99m-sestamibi uptake by human benign and malignant breast tumor cells: correlation with mdr gene expression.

Authors:  M D Cordobes; A Starzec; L Delmon-Moingeon; C Blanchot; J C Kouyoumdjian; G Prévost; M Caglar; J L Moretti
Journal:  J Nucl Med       Date:  1996-02       Impact factor: 10.057
  2 in total
  1 in total

1.  Correlation of expression of multidrug resistance protein and messenger RNA with 99mTc-methoxyisobutyl isonitrile (MIBI) imaging in patients with hepatocellular carcinoma.

Authors:  Hai Wang; Xiao-Ping Chen; Fa-Zu Qiu
Journal:  World J Gastroenterol       Date:  2004-05-01       Impact factor: 5.742
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.